Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children-Reference-Cited by-同舟云学术

Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children

Published:2011-04 Issue:19 Volume:29 Page:3548-3557
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Meier Sara,Bel Michael,L’Huillier Arnaud,Crisinel Pierre-Alex,Combescure Christophe,Kaiser Laurent,Grillet Stéphane,Pósfay-Barbe Klara,Siegrist Claire-Anne

Funder

Center de Recherche Clinique of the University Hospitals of Geneva

Medical Faculty of Geneva

Louis Jeantet Foundation

the Center of Vaccinology

Swiss Federal Office of Public Health

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference32 articles.

1. World Health Organisation. DG statement following the meeting of the Emergency Committee. 2009 19.4.2010], Available from: http://www.who.int/csr/disease/swineflu/4th_meeting_ihr/en/index.html.

2. Swiss Federal Committee for Vaccinations. Recommendations on the vaccination against Influenza A H1N1/09 as of August 13th 2009 (document in French). 2009 3.5.2010]; Available from: http://www.bag.admin.ch/ekif/04423/04429/index.html?lang=fr&download=NHzLpZeg7t,lnp6I0NTU042l2Z6ln1ae2IZn4Z2qZpnO2Yuq2Z6gpJCHe4N5fWym162epYbg2c_JjKbNoKSn6A--.

3. Swiss Federal Office of Public Health. Overview of H1N1 Vaccines (document in French). 2009 4.5.2010]; Available from: http://www.bag.admin.ch/influenza/01120/01134/index.html?lang=fr&download=NHzLpZeg7t,lnJ6IzdeIp96km56VmmRqn5ZOqdayYLGH4crdzYam3aiFfm2svWym162epYbg2c_JjKbNoKOn6A--.

4. European Medicines Agency. Pandemrix. Summary of product characteristics, approved by the European Commission on the 8th February 2010. 2010 [cited 2010 27.8.2010], Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Other/2010/05/WC500091295.pdf.

5. European Medicines Agency, Focetria. Summary of product characteristics, approved by the European Commission on the 8th February 2010. 2010.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors affecting the immunogenicity of influenza vaccines in human;BMC Infectious Diseases;2023-04-06

2. Vaccine Immunology;Plotkin's Vaccines;2023

3. Factors affecting the immunogenicity of influenza vaccines in human;2022-12-01

4. Decreased Antibody Response After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Patients With Down Syndrome;The Journal of Infectious Diseases;2022-06-24

5. Chronic inflammation and extracellular matrix-specific autoimmunity following inadvertent periarticular influenza vaccination;Journal of Autoimmunity;2021-11